BOLDRINI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 6.798
AS - Asia 2.487
EU - Europa 2.371
SA - Sud America 516
AF - Africa 165
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.346
Nazione #
US - Stati Uniti d'America 6.624
CN - Cina 893
SG - Singapore 662
IT - Italia 644
BR - Brasile 468
SE - Svezia 446
HK - Hong Kong 390
DE - Germania 330
BG - Bulgaria 252
TR - Turchia 166
GB - Regno Unito 163
CA - Canada 148
FI - Finlandia 121
VN - Vietnam 119
RU - Federazione Russa 110
UA - Ucraina 82
CI - Costa d'Avorio 68
FR - Francia 51
IN - India 51
AT - Austria 49
SN - Senegal 36
BD - Bangladesh 30
CH - Svizzera 29
KR - Corea 28
IQ - Iraq 26
BE - Belgio 21
JP - Giappone 18
NL - Olanda 18
UZ - Uzbekistan 16
AR - Argentina 14
MX - Messico 13
NG - Nigeria 13
PL - Polonia 13
PK - Pakistan 12
ZA - Sudafrica 11
VE - Venezuela 10
SA - Arabia Saudita 9
AU - Australia 8
ES - Italia 8
IE - Irlanda 8
CO - Colombia 7
EG - Egitto 7
JO - Giordania 7
MA - Marocco 7
LT - Lituania 6
AZ - Azerbaigian 5
ID - Indonesia 5
IL - Israele 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
CZ - Repubblica Ceca 4
KE - Kenya 4
KZ - Kazakistan 4
LB - Libano 4
NP - Nepal 4
PH - Filippine 4
TN - Tunisia 4
DZ - Algeria 3
EC - Ecuador 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
PY - Paraguay 3
RO - Romania 3
ZW - Zimbabwe 3
BB - Barbados 2
BH - Bahrain 2
BJ - Benin 2
BN - Brunei Darussalam 2
CG - Congo 2
CR - Costa Rica 2
ET - Etiopia 2
GY - Guiana 2
HU - Ungheria 2
IR - Iran 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MD - Moldavia 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BS - Bahamas 1
BW - Botswana 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
KG - Kirghizistan 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NA - Namibia 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
Totale 12.341
Città #
Fairfield 734
Ashburn 709
Woodbridge 587
Chandler 574
Santa Clara 488
Ann Arbor 466
Houston 431
Hong Kong 384
Seattle 298
Singapore 283
Sofia 252
Cambridge 248
Wilmington 247
Shanghai 229
Beijing 202
New York 172
Ottawa 126
Boardman 118
Princeton 111
Izmir 106
Jacksonville 105
Pisa 105
Lawrence 101
Medford 95
Milan 93
Nanjing 91
Serra 88
Des Moines 70
Florence 69
Abidjan 68
Hefei 50
São Paulo 46
Istanbul 45
Frankfurt am Main 44
Los Angeles 44
Munich 44
The Dalles 42
Columbus 41
Vienna 38
Dakar 36
Dong Ket 36
San Diego 36
Boulder 35
Dearborn 33
Council Bluffs 30
Nanchang 30
Ogden 29
Bremen 28
Kunming 26
Bern 24
Seoul 24
Falls Church 22
Shenyang 22
Lancaster 21
London 20
Brussels 19
Chicago 19
Hebei 19
Turku 19
Jüchen 17
Fuzhou 16
Redwood City 16
Rio de Janeiro 16
Rome 16
Guangzhou 15
Tashkent 15
Baghdad 14
Pune 14
Tokyo 14
Düsseldorf 13
Helsinki 13
Cascina 12
Dallas 12
Hangzhou 12
Phoenix 12
Belo Horizonte 11
Changsha 11
Lagos 11
Nürnberg 11
Washington 11
Nuremberg 10
Seacroft 10
Warsaw 10
Auburn Hills 9
Jiaxing 9
Toronto 9
Dhaka 8
Jinan 8
Norwalk 8
Porto Alegre 8
San Francisco 8
Alessandria 7
Amman 7
Guarulhos 7
Johannesburg 7
Redmond 7
Tianjin 7
Boston 6
Falkenstein 6
Lappeenranta 6
Totale 9.011
Nome #
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines 206
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance 175
Evaluation of telomerase in the development and progression of colon cancer. Int J Mol Med. 2002 Nov;10(5):589-92 174
EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center 163
Targeting of O6-methylguanine-DNA methyltransferase (MGMT) activity by antimessenger oligonucleotide sensitizes CHO/mex+ transfected cells to Mitozolomide 161
Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features 159
Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures. 156
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. 156
C-MYC, HIF-1α, ERG, TKT, and GSTP1: an Axis in Prostate Cancer? 156
Distinct Angiogenic microRNA-mRNA Expression Profiles Among Subtypes of Lung Adenocarcinoma. 155
Mutations of Fas (APO-1/CD95) and p53 genes in nonmelanoma skin cancer 150
Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression 149
3T3 NIH murine fibroblasts and B78 murine melanoma cells expressing the "E. coli" N3-methyladenine-DNA glycosylase I do not become resistant to alkylating agents" 148
A high vascular count and overexpression of Vascular Endothelial Growth Factor (VEGF) are associated with unfavorable prognosis in operated Small Cell Carcinoma (SCLC) 148
Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessment. 147
EZH2 Expression in Intestinal Neuroendocrine Tumors 147
Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study 146
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 145
CD34 microvessel density and VEGF expression in basal and squamous cell carcinoma 143
Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer 141
Analysis of Fusion Genes by NanoString System: A Role in Lung Cytology? 141
Inherited germline T790M mutation and somatic epidermal growth factor receptor mutations in non-small cell lung cancer patients 139
null 138
P2X7 protein expression and polymorphism in non-small cell lung cancer (NSCLC). 138
Management of peritoneal carcinomatosis with cytoreductive surgery combined with intraperitoneal chemohyperthermia at a novel italian center 136
Neoangiogenesis as prognostic indicator of survival in lung cancer. 135
Expression and function of P2X7 receptor in papillary thyroid cancer: a new potential marker of the disease? 134
Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction 133
Proposal for a New Diagnostic Histopathological Approach in the Evaluation of Ki-67 in GEP-NETs 132
Quantitation of in vitro activity of synthetic trans-acting ribozyme using HPLC 131
null 130
Evaluation of telomerase in non-melanoma skin cancer 129
Immunohistochemical and molecular study of radiation-induced multiple meningiomas with pleural and pulmonary metastasis 128
Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations 127
VALUTAZIONE DELL'ATTIVITA' TELOMERASICA E DELL'ESPRESSIONE DI hTERT mRNA IN ADENOCARCINOMA DEL COLON 126
A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma 126
Differential microRNA expression profiles between young and old lung adenocarcinoma patients. 122
Primary small cell carcinoma of the ureter: Case report and review of the literature 122
Expression profiling and microRNA regulation of the LKB1 pathway in young and aged lung adenocarcinoma patients 121
COINVOLGIMENTO DEL SISTEMA FAS(CD95/APO-1)/FAS LIGANDO NEL PROCESSO DI APOPTOSI p53-MEDIATO IN ADENOCARCINOMI DEL COLON 120
Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction 119
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 119
The genotoxicity of the chlroethylating agent Mitozolomide is enhanced in CHO MEX+ cells by the administration of antimessenger oligonucleotide targeted against Methylguanine-DNA methyltransferase gene (MGMT) 118
Alterazioni del gene Fas (APO-1/CD95) nei carcinomi polmonari non a piccole cellule (NSCLC). Correlazioni con le alterazioni del gene P53. 117
The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib 116
null 116
Expression of p-AKT and p-mTOR in a large series of bronchopulmonary neuroendocrine tumors 116
Regulation of telomerase and its hTERT messenger in colorectal cancer 115
Evaluation of telomerase mRNA (hTERT) in colon cancer 114
Expression Profiling of LKB1 Pathway in Young and Old Lung Adenocarcinoma Patients. 114
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance 112
null 111
Effect of Interferon-α and β on FAS mediated apoptosis and IL-6 release in Human primary thyrocytes 111
Delta N133p53 Expression Levels in Relation to Haplotypes of the TP53 Internal Promoter Region 111
Neoangiogenesis in colon cancer: Correlation between vascular density, vascular endothelial growth factor (VEGF) and p53 protein expression 110
The role of somatostatin in vasogenic meningioma associated brain edema 108
Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma. 107
Meningioma-associated brain oedema: the role of angiogenic factors and pial blood supply 105
Telomerase in intracranial meningiomas 105
NEOANGIOGENESI IN ADENOCARCINOMI DEL COLON 104
Osteopontin expression and prognostic significance in non-small cell lung cancer 102
Tumor necrosis factor/a and trasforming growth/b are significantly associated with better prognosisi in non small cell lung carcinoma: putative relation with bcl-32-mediated neovascularization 101
Vascular endothelial growth factor is associated with neovascularization and influences progression in Non Small Cell Lung Carcinoma (NSCLC). Clin Cancer Research 3: 861-865, 1997 100
Quantitation by competitive PCR assay of vascular endothelial growth factor (VEGF) in non-small cell lung carcinomas 100
null 100
Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas 98
null 98
Differential microRNA Expression Profile between Young and Old Lung Adenocarcinoma Patients. 96
Unusual Case of Pancreatic Adenocarcinoma with Bladder Metastasis 94
Mutational analysis in cytological specimens of advanced lung adenocarcinoma: A sensitive method for molecular diagnosis 93
Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients 91
Interferon Beta induces IL-6 release but not apoptosis in primary cultures of human thyrocytes 90
Modulation of neoangiogenesis in bronchial preneoplastic lesions 90
TSP1 and TSP2 mRNA expression in lung carcinoma: relation with p53 alterations, angiogenic growth factors and vascular density 89
Vascular endothelial growth factor is associated with neovascularization and influences progression in Non Small Cell lung Carcinoma (NSCLC) 89
Telomerase activity and hTERT mRNA expression in gliomas 89
Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen? 89
p16 and its putative interplay with metabolic factors in prostate cancer: An analysis based on public TCGA data 89
Polymorphisms within inflammatory genes and colorectal cancer 87
Intraductal prostate cancer: An aggressive subset of prostate cancers? Immunophenotypic evaluation 87
Bel2 and p53 regulate vascular endothelial growth factor(VEGF)-mediated angiogenesis in non-small cell lung carcinoma. 86
null 83
Role of endothelin-1 in angiogenic phenomenon in intracranial meningiomas 77
WSB1 Involvement in Prostate Cancer Progression 76
Non-small-cell lung cancer in women: Clinical and molecular aspects 76
Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization 76
Regulation of telomerase and its hTERT messenger in colorectal cancer 73
Response to erlotinib in a patient with lung adenocarcinoma harbouring the EML4-ALK translocation: A case report. 73
Non-small-cell lung cancer in women: Clinical and molecular aspects 72
Expression of endothelia-1 is related to poor prognosis in non-small cell lung carcinoma Anno 2005 Titolo della Rivista Titolo EUROPEAN JOURNAL OF CANCER ISSN 0959-8049 71
Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer 71
PLLA/Gelatine Spongy Matrices for the Regeneration of Bone Tissue 69
Expression of endothelin-1 (ET-1) and cyclooxygenase-2 (COX-2) in intracranial meningiomas 69
Thrombospondins I and II messenger RNA expression in lung carcinoma: Relationship with p53 alterations, angiogenic growth factors, and vascular density 66
Expression of miRNA-25 in young and old lung adenocarcinoma 66
null 65
null 63
null 63
null 63
Epidermal growth factor receptor and K-RAS mutations in 411 lung adenocarcinoma: A population-based prospective study 63
Totale 11.274
Categoria #
all - tutte 36.946
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.946


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021815 55 48 45 37 156 44 40 64 80 45 47 154
2021/20221.260 10 83 55 75 272 190 39 74 50 36 46 330
2022/20231.554 171 173 112 166 166 221 5 125 292 5 111 7
2023/2024925 86 78 126 34 137 194 32 44 17 14 60 103
2024/20253.666 29 127 24 213 394 443 327 190 349 459 382 729
2025/2026110 110 0 0 0 0 0 0 0 0 0 0 0
Totale 12.536